PharmacyCodes



Levosulpiridum [Inn-Latin] en es it fr

Levosulpiridum [Inn-Latin] Brand names, Levosulpiridum [Inn-Latin] Analogs

Levosulpiridum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Levosulpiridum [Inn-Latin] Chemical_Formula

C15H23N3O4S

Levosulpiridum [Inn-Latin] RX_link

No information avaliable

Levosulpiridum [Inn-Latin] fda sheet

Levosulpiridum [Inn-Latin] msds (material safety sheet)

Levosulpiridum_[Inn-Latin] MSDS

Levosulpiridum [Inn-Latin] Synthesis Reference

No information avaliable

Levosulpiridum [Inn-Latin] Molecular Weight

341.427 g/mol

Levosulpiridum [Inn-Latin] Melting Point

178 oC

Levosulpiridum [Inn-Latin] H2O Solubility

2280 mg/L

Levosulpiridum [Inn-Latin] State

Solid

Levosulpiridum [Inn-Latin] LogP

1.337

Levosulpiridum [Inn-Latin] Dosage Forms

Tablet

Levosulpiridum [Inn-Latin] Indication

Sulpiride is indicated for the treatment of schizophrenia.

Levosulpiridum [Inn-Latin] Pharmacology

Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.

Levosulpiridum [Inn-Latin] Absorption

No information avaliable

Levosulpiridum [Inn-Latin] side effects and Toxicity

No information avaliable

Levosulpiridum [Inn-Latin] Patient Information

No information avaliable

Levosulpiridum [Inn-Latin] Organisms Affected

Humans and other mammals